- VE800, is based on work showing in preclinical models that certain gut-dwelling bacterial strains potentiate cytotoxic CD8+ T cells and enhance infiltration into tumors
- Bristol-Myers... read more
Biological Dynamics announced on 12/7/18 that its OmniVerita system has been selected as the winner of CONNECT’s Most Innovative New Product Award in the Life Science Products, Clinical Stage... read more
Kallyope Inc., a leading biotechnology company focused on identifying therapeutic opportunities involving the gut-brain axis, today announced a $21 million expansion of its previously... read more
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,